EUVIMEDEUVIMED entdecken
Crossref

Early attainment of isavuconazole target concentration using an increased loading dose in critically ill patients with extracorporeal membrane oxygenation

Stefan Hatzl, Lisa Kriegl, Florian Posch, Gernot Schilcher, Philipp Eller iD, Alexander Reisinger, Yvonne Grinschgl, Tina Muhr, Andreas Meinitzer, Martin Hoenigl iD, Robert Krause

Journal of Antimicrobial Chemotherapy · 2023

DOI: 10.1093/jac/dkad328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Stefan Hatzl und 10 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Unit, Department of Internal Medicine, Medical University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In critically ill patients with extracorporeal membrane oxygenation (ECMO) attainment of target concentration of isavuconazole is delayed using the routine loading dose.

Objectives

We investigated the influence of increasing the first loading dose of isavuconazole on plasma concentrations in critically ill patients treated with ECMO.

Methods

Fifteen patients were included in this study, and isavuconazole concentrations were measured at several timepoints starting 2 h after the first isavuconazole dose up to 168 h. By interim analysis of isavuconazole concentrations and meticulous screening for adverse events, the first loading dose was stepwise increased from 200 to 300 mg, and finally to 400 mg.

Results

Seven of 15 patients (47%) received standard isavuconazole loading dosage with 200 mg as the first dose, 3/15 (20%) received 300 mg, and 5/15 (33%) received 400 mg isavuconazole as the first dose, followed by subsequent standard dosing in all patients. In patients receiving 400 mg as the first dose all isavuconazole concentrations were significantly higher at timepoints up to the first 24 h, resulting in higher proportions of isavuconazole concentrations ≥1 mg/L compared with patients with other loading dosages. In timepoints ≥24 h after isavuconazole initiation all patient groups reached comparable plasma concentrations, regardless of the first loading dose regimen. We did not observe concentrations above ≥5 mg/L or any adverse events related to isavuconazole administration.

Conclusions

In critically ill patients with ECMO the 400 mg loading dose of isavuconazole resulted in immediate median isavuconazole plasma concentrations ≥1 mg/L and remained constant above this threshold after the first loading dose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationHumansCritical IllnessNitrilesPyridinesTriazoles

Substanzen

NitrilesPyridinesisavuconazoleTriazoles

Autor:innen und Institutionen

  • Intensive Care Unit, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, A-8036, Graz, Austria.
  • Division of Haematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Department of Anaesthesiology and Intensive Care Medicine, Medical University of Graz, Graz, Austria.

ORCID-Profile: Philipp Eller, Martin Hoenigl

Förderung

  • Pfizer

Zitieren

APA

Hatzl, S., Kriegl, L., Posch, F., Schilcher, G., Eller, P., Reisinger, A., Grinschgl, Y., Muhr, T., Meinitzer, A., Hoenigl, M., & Krause, R. (2023). Early attainment of isavuconazole target concentration using an increased loading dose in critically ill patients with extracorporeal membrane oxygenation. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad328

Vancouver

Hatzl S, Kriegl L, Posch F, Schilcher G, Eller P, Reisinger A, et al. Early attainment of isavuconazole target concentration using an increased loading dose in critically ill patients with extracorporeal membrane oxygenation. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad328

BibTeX
@article{Hatzl2023,
  author = {Hatzl, Stefan and Kriegl, Lisa and Posch, Florian and Schilcher, Gernot and Eller, Philipp and Reisinger, Alexander and Grinschgl, Yvonne and Muhr, Tina and Meinitzer, Andreas and Hoenigl, Martin and Krause, Robert},
  title = {Early attainment of isavuconazole target concentration using an increased loading dose in critically ill patients with extracorporeal membrane oxygenation},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  doi = {10.1093/jac/dkad328}
}
Kostenlos starten →